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ABSTRACT
Borrelia burgdorferi produces Erp outer surface
proteins throughout mammalian infection, but
represses their synthesis during colonization of
vector ticks. A DNA region 50 of the start of erp tran-
scription, Operator 2, was previously shown to be
essential for regulation of expression. We now
report identification and characterization of a novel
erp Operator 2-binding protein, which we named
BpaB. erp operons are located on episomal cp32
prophages, and a single bacterium may contain as
many as 10 different cp32s. Each cp32 family
member encodes a unique BpaB protein, yet the
three tested cp32-encoded BpaB alleles all bound
to the same DNA sequence. A 20-bp region of erp
Operator 2 was determined to be essential for BpaB
binding, and initial protein binding to that site was
required for binding of additional BpaB molecules. A
36-residue region near the BpaB carboxy terminus
was found to be essential for high-affinity
DNA-binding. BpaB competed for binding to erp
Operator 2 with a second B. burgdorferi DNA-
binding protein, EbfC. Thus, cellular levels of free
BpaB and EbfC could potentially control erp tran-
scription levels.
INTRODUCTION
The Lyme disease spirochete, Borrelia burgdorferi, persists
in nature through infectious cycles between vertebrate
hosts and Ixodes spp. tick vectors. Human infection is gen-
erally accompanied by an expanding ‘bull’s-eye’-shaped
rash and nonspeciﬁc symptoms such as fever, aches and
malaise. Untreated, B. burgdorferi infections may manifest
as signiﬁcant inﬂammatory arthritis, carditis and/or
neurological disorders (1,2).
Borrelia burgdorferi produces proteins that are speciﬁc
for each stage of its vertebrate-arthropod infectious cycle.
Among these are the Erp proteins, a polymorphic family
of surface-exposed outer membrane lipoproteins that are
highly expressed during all stages of mammalian infection
but largely repressed during tick colonization (3,4).
Among the known functions of Erp proteins are adher-
ence to host laminin and the binding of host plasminogen,
complement regulator factor H and the factor H-related
proteins FHR-1, FHR-2 and FHR-5 (5–15). These
infection-associated functions make Erp proteins attract-
ive targets for developing new protective and curative
therapies for Lyme disease.
All Lyme disease spirochetes naturally contain multiple,
distinct 32-kb circular prophages, collectively called cp32s
(3,16). Each cp32 contains a mono- or bicistronic erp
locus. Nine diﬀerent erp-containing cp32s are present in
the B. burgdorferi type strain, B31 (16–18). A 10th erp
locus is found in strain B31 on a mutant cp32 known as
lp56, an  56-kb linear plasmid that consists of an entire
cp32 integrated into an unrelated linear replicon (17–19).
Another natural plasmid of strain B31, named cp9-1,
evolved from a cp32 through a series of deletion and
rearrangement mutations, and no longer carries an erp
locus (18).
All erp loci contain highly conserved DNA sequences 50
of the open reading frames (Figure 1A). Genetic and
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erp loci contain binding sites for B. burgdorferi cytoplas-
mic proteins (20). The DNA region closest to the tran-
scriptional start site, Operator 2, appears to play a role
in transcriptional regulation, as deletion of that sequence
resulted in constitutive, high-level transcription (20).
DNA-aﬃnity chromatography indicated that at least
three proteins speciﬁcally bind to erp 50 DNA (21). We
previously identiﬁed one of these as EbfC, which is a
novel type of DNA-binding protein that is encoded on
the borrelial main chromosome. EbfC preferentially
binds the palindromic sequence GTnAC, where ‘n’ can
be any base, with all erp Operator 2 regions containing
two adjacent EbfC-binding sites (21,22). We now report
identiﬁcation and characterization of a family of closely
related borrelial proteins named BpaB (Borrelial ParB
analog) that also bind erp Operator 2 DNA. All cp32
family members encode a BpaB protein, which appears
to play a role in replication and segregation, possibly
analogous to the ParB DNA-binding proteins of low
copy-number plasmids in other bacterial species
(18,23–29). Predicted protein sequences of BpaB proteins
are distinct from any known plasmid partition-segregation
protein, and may represent a novel type of such proteins
(18,24,28). Some species’ ParB proteins are known to also
be involved in plasmid gene regulation, by binding speciﬁc
DNA sites and occluding promoter elements (23,30–33).
We therefore analyzed the DNA-binding characteristics of
BpaB proteins encoded by cp32 family members.
MATERIALS AND METHODS
Bacteria
The B. burgdorferi type strain, B31, was the original
source for all DNAs and recombinant proteins used in
these studies. The complete genome sequence of a subcul-
ture of strain B31, known as B31-MI, has been determined
(18,34). Strain B31-MI contains nine cp32 family
members: cp32-1, cp32-3, cp32-4, cp32-6, cp32-7, cp32-8,
cp32-9, cp9-1 and lp56. Two additional cp32 replicons,
cp32-2 and cp32-5, have been found in other subcultures
of the original B31 isolate, and have been partially
sequenced (16,17). A 12th cp32 family member, cp9-2,
was identiﬁed in another B31 derivative, but its probable
bpaB locus has yet to be sequenced (35).
Modeling analyses
Primary amino acid sequences of proteins were
compared with all known sequences in the
nonredundant protein sequence database of GenBank
using BLAST-P and Psi-BLAST (http://www.ncbi.nlm
.nih.gov/BLAST). Protein folding probabilities were
determined using Protein Homology/analogY
Recognition Engine (PHYRE) (http://www.sbg.bio.ic.ac
.uk/ phyre). Predictions of disorder within proteins
were determined using Predictor of Naturally Disordered
Regions (PONDR, www.pondr.com) using VL-XT.
Access to PONDR was provided by Molecular
Kinetics (Indianapolis, IN, USA). VL-XT is copy-
right1999 by the WSU Research Foundation, all rights
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Kinetics, all rights reserved. Probabilities of coiled-coil
formation by proteins were determined using COILS
(http://www.ch.embnet.org/software/COILS_form.html)
and PCOILS (http://toolkit.tuebingen.mpg.de/pcoils).
Recombinant proteins
All recombinant proteins contained amino-terminal
polyhistidine tags. Alleles of bpaB were named according
to the replicon on which the gene is located, e.g. cp32-1
contains bpaB321, lp56 contains bpaB56, cp9-1 contains
bpaB9, lp38 carries bpaB38, etc. For production of
full-length recombinant BpaB321, BpaB56, BpaB9 and
BpaB38, their respective genes were polymerase chain
reaction (PCR)-ampliﬁed and cloned into pET200-
TOPO (Invitrogen). Plasmids encoding truncated
BpaB321 proteins were produced by sequence overlap ex-
tension PCR mutagenesis (36) of the full-length BpaB321
expression plasmid. Inserts of all recombinant plasmids
were completely sequenced on both strands to conﬁrm
expected results. Recombinant EbfC was produced using
a previously described plasmid (21). Escherichia coli strain
Rosetta(DE3)(pLysS) (Invitrogen) was individually trans-
formed with each plasmid. Production of recombinant
proteins was induced by addition of isopropyl-b-D-
galactopyranose (IPTG, ﬁnal concentration 1mM) to
mid-exponential phase 37 C cultures, then incubated over-
night with aeration at room temperature. Alternatively,
E. coli were grown overnight at 37 C in 100ml expansion
broth (Zymo Research), inoculated into 500ml
over-expression broth (Zymo Research) the following
day, then cultured for another 24h at 37 C. Bacteria
were harvested by centrifugation. Cells were resuspended
in binding buﬀer (20mM NaPO4, 1M NaCl, 30mM imid-
azole, pH 7.4), and bacteria lysed by sonication. Lysates
were cleared by centrifugation at 15000g, then injected
onto a pre-equilibrated 5ml HisTrap-HP column on an
AKTA-FPLC with a UPC-900 absorbance monitor and
a Frac920 fraction collector (all GE Healthcare). The
column was washed with 15 column volumes of binding
buﬀer, followed by linear gradient elution with imidazole
concentrations steadily increasing from 30 to 750mM.
Aliquots of eluted fractions were analyzed for purity by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and Coomassie brilliant blue staining.
Proteins were then dialyzed against 50mM Tris–HCl,
pH=7.5, 1mM phenylmethanesulfonyl ﬂuoride
(PMSF), 1mM dithiothreitol (DTT) and 10% (vol/vol)
glycerol. Final protein concentrations were determined
by bicinchoninic acid (BCA) protein assay (Pierce).
Puriﬁed, dialyzed proteins were snap frozen in liquid
nitrogen and stored at  80 C.
Electrophoretic mobility shift assays
A previously constructed recombinant plasmid containing
B31 erpAB1 50 non-coding DNA (including Operator 2)
served as template for sequence overlap extension
PCR mutagenesis of erp Operator 2 DNA (21,36),
deleting 20bp from erp Operator 2 to yield pBLS672.
The erp 50 noncoding sequence of that mutant plasmid
was completely sequenced on both strands to conﬁrm
expected results.
The wild-type erp Operator 2-containing plasmid was
used as template for producing wild-type electrophoretic
mobility shift assay (EMSA) probe b-WT and the labeled
probes used in simultaneous EMSA studies which initially
identiﬁed the high-aﬃnity, initial binding site of BpaB
competitor DNAs. Plasmid pBLS672 served as template
for production of probe b-672. For each of these labeled
probes, the upstream primer used had been modiﬁed with
a biotin moiety on the 50 end. For unlabeled DNA
competitors, unmodiﬁed oligonucleotides were used.
Ampliﬁcation products were separated by agarose gel elec-
trophoresis, the appropriate band excised, and DNA
cleaned using Wizard SV gel puriﬁcation systems
(Promega). Prior to use in EMSA, the concentration of
each probe was determined spectrophotometrically (A260
of 1.0=50mg DNA/ml), then diluted to a concentration
of 1nM. EMSA reactions were performed in 20ml total
volumes, containing 2fmol biotinylated DNA probe in
50mM Tris–HCl (pH=7.5), 1mM dithiothreitol,
8ml/ml protease inhibitor (Sigma, St. Louis, MO, USA),
2ml/ml phosphatase inhibitor cocktail II (Sigma), 50mg/ml
bovine serum albumin, 10% glycerol, 40ng/ml
poly(dI–dC) (Sigma), and various concentrations of re-
combinant protein. Reaction mixes were incubated for
20min at room temperature, followed by electrophoresis
in pre-cast 6% acrylamide gels (Invitrogen) for 90min at
100V. DNAs were transferred to nylon membranes
(Pierce), and cross-linked by exposure to ultraviolet
(UV) light. Labeled DNAs were detected using chemilu-
minescent nucleic acid detection kits (Pierce) and exposure
to Kodak Biomax ﬁlm.
Radiolabeled EMSA probes r-40 and r-23 were
produced from pairs of complimentary oligonucleotides
either 40 or 23bp in length, respectively (Figure 1).
Following are details on production of probe r-40.
Probe r-23 was produced in exactly the same manner,
except with use of oligonucleotides 23-F and 23-R. For
probe r-40, two complimentary 40 base sequences, 40-F
and 40-R, were synthesized. Oligonucleotide 40-F was
50-end labeled using g-
32P-ATP (Perkin-Elmer) and
T4 Kinase (New England Biolabs). The radiolabeled
DNA was ethanol precipitated, resuspended in H20,
passed through a Sephadex 10 (Sigma) column and
dialyzed in TE buﬀer, pH=8. A 1.2-fold excess of the
complementary oligomer, 40-R, was added to the
radiolabeled 40-F oligomer. The DNAs were annealed
by ﬁrst incubating for 5min in a boiling water bath,
then the heat turned oﬀ and allowed to cool to  37 C
(3–4h). The resulting dsDNA was dialyzed with EMSA
buﬀer. Varying concentrations of puriﬁed BpaB321
protein were added to 0.2mM
32P-labeled r-40, and
mixtures were equilibrated at 4 C for 4h.
Electrophoresis was carried out in an 8% polyacrylamide
gel using low salt TAE buﬀer 0.8MTris and 0.02M
EDTA pH 7.6. Autoradiographic images were captured
on storage phosphor screens (type GP, GE Healthcare)
detected with a Storm phosphorimager and quantitated
with Image-Quant software (GE Healthcare).
Nucleic Acids Research, 2010,Vol.38, No. 16 5445For studies to determine binding constants, a lumines-
cent form of wild-type erpAB Operator 2 probe b-WT was
produced. The upstream primer had been modiﬁed with
an IRDye 700 ﬂuorescent infrared dye at its 50-end
(LI-COR). Ampliﬁcation products were separated by
agarose gel electrophoresis, the appropriate DNA band
excised, then cleaned as above. EMSAs were carried out
as described previously. Luminescent DNA bands were
detected using an Odyssey Infrared Imaging System
(LI-COR). Disassociation constants (Kd) for BpaB–
DNA interactions were determined by comparing the
signal strengths of bound and unbound DNA in each
reaction. Signal strengths were normalized for each lane.
Ratios of bound:free DNA were graphed in relation to
the known concentrations of free protein [P], using
Microsoft Excel. Since the ratios of free protein to DNA
were extremely high, the binding of protein to DNA did
not appreciably change the concentration of free protein
(37) The disassociation constant was therefore calculated
as the concentration of BpaB where the ratio of bound to
free DNA=1 (22,37–39).
Analyses of DNA conformation
Five 150-bp DNA fragments, overlapping stepwise by
30-bp increments over a total of 250bp, were produced
by PCR, using the cloned erpAB insert of pBLS434a as
template (16,22). The upstream oligonucleotide primer for
each DNA fragment was modiﬁed with a biotin moiety at
the 50 end. Natural curvature of the DNAs was analyzed
by electrophoresis through 15% polyacrylamide gels and
staining with ethidium bromide. EMSA using puriﬁed
recombinant BpaB321 was performed as described
previously.
RESULTS
BpaB binds to erp Operator 2 DNA
We previously reported that DNA-aﬃnity chromatog-
raphy using erp 50 noncoding DNA and B. burgdorferi
cytoplasmic extracts led to isolation of three diﬀerent
proteins (21). Subsequent mass spectrometric analyses of
tryptic fragments of the largest,  22-kDa, erp-binding
protein suggested it to be encoded by a gene located on
the B. burgdorferi cp32 prophages (data not shown). These
genes have been implicated in plasmid maintenance, and
have been variously referred to as ORF-3, ORF-D,
paralog family 49 or pfam01672 (18,19,24,26,28,40,41).
Due to apparent functional similarities between the
 22-kDa proteins encoded by these borrelial genes and
the ParB/SopB proteins of other bacterial species, we
named the borrelial proteins ‘BpaB’ (Borrelial ParB
analog). The validity of this proteomic identiﬁcation of
BpaB as an erp-binding protein was investigated by
EMSA using labeled DNA probe b-WT, derived from
the wild-type erpAB1 locus (Figure 1B), and recombinant
BpaB allele 321, based on the bpaB gene sequence of
B. burgdorferi strain B31 cp32-1. Incubation of probe
b-WT with BpaB321 protein yielded slowly migrating
EMSA bands, consistent with DNA-protein complexes
(Figure 2A). Preincubation of recombinant protein and
DNA at room temperature, 4 Co r3 7  C made no signiﬁ-
cant diﬀerences in protein binding, so all subsequent
EMSAs were performed at room temperature
(Figure 2A, lanes 2–4). BpaB speciﬁcity for erp Operator
2 DNA was assessed by competition EMSA using excess
quantities of unlabeled DNAs derived from either erp 50
DNA or from an unrelated source. Competitor C-100,
which consists of part of erp Operator 2, partially
inhibited formation of the protein–DNA complexes
(Figure 2A, lane 5). A 100-fold excess of unlabeled
DNA identical in sequence to the labeled probe almost
completely eliminated the protein–DNA complex bands
(Figure 2A, lane 6). However, addition of a 100-fold
excess of unlabeled DNA derived from the promoter
region of the unrelated B. burgdorferi ﬂaB gene did not
have any detectable eﬀects on DNA–protein complex for-
mation (Figure 2A, lane 7). As additional controls,
heating recombinant BpaB321 in a boiling water bath
for 10min prior to incubation with DNA, or addition of
Figure 2. Demonstration that BpaB binds speciﬁcally to erp Operator
2 DNA. (A) EMSA with labeled erp probe b-WT and puriﬁed recom-
binant protein based on the sequence of bpaB from B. burgdorferi strain
B31 cp32-1 (BpaB321). Lane 1 lacked added BpaB321, while 0.12mM
recombinant protein was added to the other lanes. (Lanes 2–4)
Pre-incubation of DNA and protein at room temperature, 4 C and
37 C, respectively. (Lanes 5–7) DNA and protein mixtures were
preincubated with 100-fold excesses of unlabeled competitor DNAs
C-100, unlabeled-WT, or ﬂaB, respectively. (Lane 8) BpaB321 was
heated in a boiling water bath for 10min prior to mixture with
DNA. (Lane 9) 10% SDS, ﬁnal concentration, was added to the
DNA–protein mixture prior to EMSA. (B) Supershift EMSA using
BpaB-directed antibodies. Lane 1 contained only DNA, lane 2 con-
tained DNA plus 0.19mM BpaB321, and lanes 3–10 contained the
same concentrations of DNA and BpaB321 plus increasing concentra-
tions of anti-BpaB321 polyclonal antiserum.
5446 Nucleic Acids Research, 2010,Vol.38, No. 16SDS (ﬁnal concentration 10%) to the DNA–protein
mixture prevented formation of the upper bands, consist-
ent with compositions that include protein (Figure 2A,
lanes 8 and 9).
Conﬁrmation that the slowly migrating bands consisted
of DNA–BpaB complexes was obtained by antibody
super-shift studies. Addition of increasing concentrations
of polyclonal rabbit antiserum raised against and speciﬁc
for BpaB led to the appearance of EMSA bands with even
slower mobilities, consistent with DNA–BpaB–antibody
complexes (Figure 2B). Antibodies in the absence of
BpaB did not aﬀect levels of free DNA (data not shown).
Initial EMSAs, such as those shown in Figure 2,
indicated multiple BpaB–DNA complexes. The natures
of these multiple complexes were investigated by addition-
al EMSA, using a constant concentration of erpAB1
Operator 2 DNA and increasing amounts of BpaB321.
These analyses revealed formation of a single protein–
DNA complex at low concentrations of BpaB321, with
additional, more slowly migrating complexes forming as
protein concentrations were increased (Figure 3A). At the
higher concentrations of BpaB321, the more rapidly
migrating DNA–protein complexes disappeared.
Additional studies described below revealed that this
pattern was due to initial binding of a BpaB protein to a
speciﬁc site on the DNA, with that bound protein
facilitating the binding of additional BpaB molecules.
Based upon the disappearance of free probe with
increasing concentrations of BpaB321, a Kd value of
190nM was calculated for the binding of protein to free
erp Operator 2 DNA. This is obviously an underestimate
of the protein’s aﬃnity for free DNA, since analyses ne-
cessarily included BpaB binding to DNA to which other
BpaB molecules had previously attached.
BpaB proteins from diﬀerent cp32 family members bind
the same DNA sequence
The BpaB proteins encoded by the diﬀerent naturally
occurring cp32 family members share   35–70% amino
acid sequence identities (Figure 4). As discussed previous-
ly and illustrated in Figure 1A, the Operator 2 sequences
of all known erp loci are highly similar. This suggested
that a protein which can bind a sequence within one erp
locus’ Operator 2 would probably be able to bind the
Operator 2 regions of other erp loci, as is the case with
EbfC (21,22). This hypothesis predicts that since BpaB
from cp32-1 binds erp Operator 2 DNA, then BpaB
proteins encoded by other cp32 family members will also
do so.
This question was ﬁrst addressed by producing and pur-
ifying a recombinant BpaB protein derived from the bpaB
allele encoded by the cp32 family member lp56 (BpaB56).
EMSA using cp32-1-derived DNA and BpaB56 yielded
banding patterns similar to those obtained when using
BpaB321 (Figure 3B). The Kd value of recombinant
BpaB56 binding to this DNA was calculated to be
220nM.
The small cp9-1 plasmid of B. burgdorferi strain B31 is a
naturally occurring cp32-derivative that had undergone
extensive mutations prior to isolation of the bacterium
from nature (18). cp9-1 lacks an erp locus, but does
encode a BpaB paralog. This protein’s predicted
sequence is <50% identical to the other cp32 family
members’ BpaB paralogs (Figure 4). It is, however, well
conserved in the carboxy-terminal region that we
identiﬁed as being involved with binding to erp Operator
2 DNA (see below). We therefore produced a recombinant
protein based on the cp9-1 sequence, BpaB9. This recom-
binant protein also yielded a laddered banding pattern
with cp32-1-derived erp Operator 2 DNA (Figure 3C).
The Kd value of recombinant BpaB9 binding to this
DNA fragment was calculated to be 530nM.
All but two of the naturally occurring plasmids of strain
B31 contain a bpaB gene (18,29). Having found that the
BpaB proteins encoded by cp32-1, lp56 and cp9-1 all bind
erpAB1 Operator 2 DNA, the obvious next step was to
examine the BpaB of a borrelial plasmid that is not related
to the cp32 family (18). To that end, a recombinant
protein was produced based on the bpaB allele of the
38-kb linear plasmid lp38, BpaB38 (Figure 4). Unlike
the cp32 family member BpaB proteins, BpaB38 was not
able to bind erp Operator 2 DNA (Figure 3D). The re-
combinant BpaB38 was produced and puriﬁed two diﬀer-
ent times, from separately transformed E. coli colonies, to
control for possible denaturation during puriﬁcation, yet
the same result was obtained from both preparations.
Figure 3. EMSA using labeled probe b-WT and increasing concentra-
tions of recombinant BpaB proteins based on sequences of B31
plasmids cp32-1, lp56, cp9-1 and lp38. For all EMSAs, lane 1 contained
DNA without protein. (A) Lanes 2–12 contained in addition 0.033,
0.066, 0.099, 0.13, 0.17, 0.20, 0.23, 0.26, 0.30, 0.33 and 0.40mM recom-
binant BpaB321 protein, respectively. (B) Lanes 2–12 contained 0.0048,
0.012, 0.024, 0.048, 0.097, 0.15, 0.19, 0.24, 0.29, 0.34 and 0.39mM
recombinant BpaB56 protein, respectively. (C) Lanes 2–12 contained
0.084, 0.17, 0.25, 0.34, 0.42, 0.50, 0.59, 0.67, 0.75, 0.84 and 1.00mM
recombinant BpaB9 protein, respectively. (D) Lanes 2–12 contained
0.069, 0.14, 0.21, 0.28, 0.35, 0.42, 0.48, 0.55, 0.62, 0.69 and 0.83mM
recombinant BpaB38 protein, respectively. Note that some of the
higher-order DNA–protein complexes do not always resolve crisply,
and appear faint or as smears in EMSAs [e.g. the upper EMSA
bands in lane 12 of (C)].
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To narrow down the high-aﬃnity BpaB-binding site, add-
itional, simultaneous EMSAs were performed. In one set
of studies, seven diﬀerent biotin-labeled DNA probes were
produced from erpAB1 50 DNA, each using the same
downstream oligonucleotide primer paired with one of
seven distinct upstream primers (Figure 5A, upper 7 se-
quences). Being of diﬀerent sizes, each DNA migrated at a
diﬀerent rate under PAGE. Equimolar amounts of all
seven DNA probes were simultaneously incubated with
various concentrations of BpaB321, then separated by
PAGE. BpaB321 bound to the largest DNA probe at
much lower protein concentrations than it did to the six
shorter probes, indicating that the largest probe contained
sequences necessary for initial high-aﬃnity binding of
BpaB, while the shorter probes lacked those bases
(Figure 5B). The same procedure was performed using
another set of seven labeled probes, this time produced
with the same upstream primer and diﬀerent downstream
primers (Figure 5A, lower 7 sequences). The longest ﬁve of
these probes bound BpaB321, indicating that they con-
tained sequences for BpaB-binding that were lacking
from the two smaller probes (Figure 5C). Comparisons
of BpaB-binding activities and the various sizes of
probes used in these studies indicated that DNA probe
size did not itself have an appreciable eﬀect upon the
results. These analyses demonstrated the presence of a
high-aﬃnity binding-site for BpaB within a region of erp
Operator 2 DNA that overlaps EbfC-binding site I
(Figures 1 and 5A). The identiﬁed DNA region is consist-
ent with additional analyses described below.
Binding of a protein often alters the conformation of
DNA, and protein-induced bending may be detected by
EMSA. To explore whether BpaB-binding distorts DNA
conformation, and to further deﬁne the location of initial
BpaB-binding in erp Operator 2 DNA, we utilized a series
of ﬁve identically sized DNA fragments of erpAB1 50
DNA that overlapped each other by 30-bp increments
(Figure 6A). PAGE of the free DNAs indicate that
erpAB1 50 DNA contains a naturally occurring bend
near the  10 site of the promoter (Figure 6 and reference
22). Addition of BpaB, at a concentration suﬃcient to
produce a single protein–DNA complex EMSA band,
yielded signals indicative of bending centered within
DNA fragment 3 (Figure 6B). The center of that DNA
fragment lies near EbfC-binding site I (Figure 6A),
indicating a location for the high-aﬃnity, initial
BpaB-binding site consistent with the results obtained
from the simultaneous EMSA studies described earlier.
Additional EMSA studies further indicated this region
of DNA to be critical for initial BpaB-binding to erp
Operator 2. Site-directed mutagenesis was utilized to
produce a labeled probe, b-672, that lacked 20bp of
erpAB1 Operator 2 but was otherwise identical to the pre-
viously used probe b-WT (Figure 1B). Simultaneous
EMSA using probes b-672 and b-WT demonstrated ap-
preciable BpaB binding to the wild-type DNA, but not to
the mutant DNA (Figure 7A). In the illustrated EMSA,
the highest concentration of BpaB assayed bound almost
F
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5450 Nucleic Acids Research, 2010,Vol.38, No. 16all the free b-WT probe, but did not bind even half of the
free mutant b-672 probe. EMSA using probe b-672 alone,
with concentrations of BpaB similar to those above,
detected very faint shifted bands upon extended ﬁlm ex-
posures, but due to the weakness of interactions, a binding
aﬃnity could not be calculated (data not shown). These
results indicate that the 20bp deleted from b-672 contain
nucleotides necessary for high-aﬃnity binding of BpaB.
Noting that the deletion of these 20bp prevented forma-
tion of any readily detectable BpaB–DNA complexes,
these experiments also demonstrated that formation of
the other BpaB–DNA complexes observed with wild-
type erp DNAs require formation of the initial DNA–
protein complex.
A second series of EMSAs utilized a 40-bp probe, r-40,
which includes the DNA regions identiﬁed by the
above-described experiments (Figure 7B). The Kd of re-
combinant BpaB321 binding to probe r-40 was calculated
to be 20mM. At most, three protein–DNA species were
detected by EMSA when using probe r-40, in con-
trast with the six complexes observed when using the
125-bp probe b-WT (Figure 3A). These data support the
hypothesis that the multiple complexes observed in
BpaB–DNA EMSAs are due to multiple protein–DNA
interactions.
The 23-bp probe, r-23, which incorporates the sequence
deleted from probe b-672, was used for additional
EMSAs. Recombinant BpaB321 bound to this small
piece of DNA with a Kd of 3.2mM (Figure 7C). Thus,
this 23-bp segment of erp Operator 2 contains a nucleotide
sequence suﬃcient for high-aﬃnity binding of BpaB. This
result is consistent with the above-described studies with
probe b-672 (Figure 7A) and with the simultaneous
EMSAs using overlapping DNA probes (Figure 5).
Identiﬁcation of the DNA-binding domain of BpaB
Comparisons of the BpaB proteins encoded by cp32
family members show limited identities in the
amino-terminal third (Figure 4). Site-directed mutagenesis
of the cp32-1-encoded BpaB was employed to produce
truncated recombinant protein N-BpaB321, which
lacks the ﬁrst 53 residues. EMSA using the truncated
protein did not show signiﬁcantly diﬀerent results from
those found with the full-length protein (Figure 8A).
Addition of increased concentrations of N-BpaB321 to
EMSA reactions yielded reduced amounts of free probe
DNA and increased laddering of protein–DNA bands.
These results indicate that the amino-terminal third of
BpaB is not required for either initial or subsequent
binding of DNA.
Truncated protein C1-BpaB321 was next produced,
lacking the carboxy-terminal 22 amino acids (Figure 4).
EMSAs using that recombinant protein were not appre-
ciably diﬀerent from those using full-length BpaB321
(Figure 8B).
A third truncated protein was produced,
C2-BpaB321, which lacks the carboxy-terminal 58
amino acids of BpaB321 (Figure 4). EMSA using this
truncated protein revealed signiﬁcantly weakened DNA
binding (Figure 8C). Laddering was not seen, even at
high protein concentrations. A single, weak, slowly
migrating signal was observed, but diminution of the
free DNA was not detected and so the binding aﬃnity
of C2-BpaB321 was too weak to be determined.
Protein C2-BpaB321 was induced and puriﬁed two
separate times, with both preparations giving the same
results, indicating that failure to bind DNA was unlikely
to have been due to denaturation during puriﬁcation.
Hence, the 36 amino acid region absent from
C2-BpaB321 but present in C1-BpaB321 is necessary
for high-aﬃnity DNA binding. Modeling analyses of
BpaB molecules predicted these proteins to be comprised
of multiple a-helices, with the 36-residue region involved
in high-aﬃnity binding predicted to be a disordered region
bridging two a-helices (data not shown). Additional
Figure 7. Conﬁrmation of the initial BpaB-binding site in erp
Operator 2 (A) Simultaneous EMSA using wild-type recombinant
BpaB321 protein and both biotin-labeled wild-type erpAB1 probe
b-WT and b-672. Probe b-672 is identical to b-WT except for
deletion of 20bp (Figure 1). Lane 1 contained only DNA. Lanes
2–12 contained BpaB321 at concentrations of 0.086, 0.18, 0.26, 0.35,
0.44, 0.53, 0.61, 0.70, 0.79, 0.86 and 1.1mM, respectively. (B) EMSA
using the radioactively labeled 40bp probe r-40 (Figure 1). Lane 1
contained only DNA. Lanes 2–20 contained BpaB321 at concentrations
of 0.40, 0.80, 1.0, 1.2, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 7.0, 10, 15, 20, 25,
30, 40 and 50mM, respectively. (C) EMSA using the radioactively
labeled 23-bp probe r-23, which encompasses the 20-bp sequence
present in b-WT but absent from b-672 (see Figure 1). Lane 1 con-
tained only DNA. Lanes 2–17 contained BpaB321 at concentrations of
0.40, 0.80, 1.0, 1.2, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 7.0, 10, 15, 20 and
30mM, respectively.
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binding to erp Operator 2 and with protein–protein inter-
actions are ongoing.
BpaB and EbfC compete for binding to erp
Operator 2 DNA
The above-described results, combined with previous data
(21,22), indicate that both BpaB and EbfC bind to
adjacent or overlapping DNA sequences of erp Operator
2 (Figure 1). To determine the eﬀects each protein has
upon DNA-binding by the other, EMSAs were performed
in which labeled erp Operator 2 DNA was preincubated
with a ﬁxed amount of one protein, then increasing
concentrations of the other protein were added.
When the concentration of BpaB321 was held constant,
increasing concentrations of EbfC led to reduced levels of
free DNA and increased levels of EbfC–DNA complexes
(Figure 9A). There were not any detectable changes
observed in band intensities of any of the BpaB–DNA
complexes. Measured ratios of free DNA signal to
BpaB–DNA complex 1 signal diminished from 3.9:1 in
lane 4 to 0.57:1 in lane 12 of Figure 9A. Thus, EbfC
preferentially bound to free erp Operator 2 DNA, as
opposed to previously formed BpaB–DNA complexes.
In other studies, the DNA probe was preincubated with
a constant level of EbfC, then BpaB concentrations were
increased. The signal strengths of EbfC–DNA complexes
and free DNA all decreased, while signal strengths of
BpaB–DNA complexes increased (Figure 9B). Thus,
under these experimental conditions, recombinant
BpaB321 can drive recombinant EbfC oﬀ Operator 2
DNA. Together, these competition EMSAs indicate that
BpaB and EbfC compete for erp Operator 2 DNA.
DISCUSSION
Previous studies by our laboratory indicated that a
conserved region immediately 50 of erp promoters,
Operator 2, is critical for repression of erp transcription.
We have now identiﬁed two diﬀerent B. burgdorferi
proteins that bind speciﬁc DNA sequences within erp
Operator 2. The high-aﬃnity BpaB-binding sequence is
adjacent to and possibly overlaps the high-aﬃnity
EbfC-binding sites. Dual protein binding assays indicated
that both BpaB and EbfC preferentially bind to free
DNA, with no evidence of both proteins binding DNA
simultaneously. Thus, it is possible that either BpaB or
EbfC is a repressor of erp transcription, while the other
protein functions as an activator/anti-repressor by
competing for erp Operator 2 DNA. This hypothesis is
currently being tested through additional studies to
correlate cellular BpaB and EbfC levels with erp
transcription.
Addition of low concentrations of BpaB to EMSA re-
actions produced a single DNA–protein complex, while
addition of increasing concentrations of BpaB yielded
increasing numbers of BpaB–DNA complexes. Deletion
of 20bp within erp Operator 2 signiﬁcantly inhibited for-
mation of any BpaB–DNA complex, indicating that this
small region must contain sequences critical for all of the
BpaB–DNA complexes formed with wild-type erp
Operator 2 DNA. Thus, we conclude that BpaB initially
forms a high-aﬃnity complex with a speciﬁc sequence
within erp Operator 2, and that subsequent binding of
BpaB to erp DNA is dependent upon that initial
binding. Presumably, protein–protein interactions
between BpaB molecules stabilize binding to non-
preferred DNA sequences. Without the speciﬁc DNA
sequence, initial BpaB binding was impaired, and so was
the binding of additional molecules. The binding of sub-
sequent BpaB proteins from a nucleation site is similar to
what has been demonstrated for several other bacterial
DNA-binding proteins, such as the spreading phenomena
of some ParB proteins and E. coli H-NS (23,30–33,42).
Figure 8. EMSAs using wild-type erpAB1 DNA and truncated
BpaB321 proteins. For all panels, lane 1 contained DNA without
protein. (A) Lanes 2–12 contained 0.013, 0.026, 0.039, 0.052, 0.065,
0.078, 0.090, 0.10, 0.12, 0.13 and 0.16mM recombinant N-BpaB321,
respectively. (B) Lanes 2–12 contained 0.078, 0.016, 0.023, 0.031, 0.039,
0.047, 0.055, 0.062, 0.070, 0.078 and 0.094mM recombinant
C1-BpaB321 respectively. (C) Lanes 2–12 contained 0.0075, 0.015,
0.023, 0.030, 0.038, 0.045, 0.053, 0.060, 0.068, 0.075 and 0.090mM
recombinant C2-BpaB321, respectively.
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encoded by the cp32 family members cp32-1, lp56 and
cp9-1 all bound to erp Operator 2 DNA, and all
produced multiple DNA–protein complexes. Analyses of
mutant proteins indicated that a 36 amino acid region in
the carboxy-terminal half of BpaB contains residues ne-
cessary for speciﬁc DNA binding. The region, between 22
and 58 residues from the carboxy-terminus, is highly
conserved among all cp32 family BpaB proteins. These
data strongly suggest that all BpaB proteins encoded by
cp32 family members can bind erp Operator 2 DNA.
In contrast, the BpaB protein encoded by the
B. burgdorferi B31 lp38 replicon did not bind erp
Operator DNA. This result is consistent with the low
degrees of similarities in the carboxy-terminal regions of
lp38 BpaB and the cp32-encoded proteins. These data also
indicate that non-cp32 replicons such as lp38 are unlikely
to directly inﬂuence erp transcription.
BpaB plays a role(s) in B. burgdorferi replicon mainten-
ance (24–27). Almost all borrelial replicons contain a bpaB
adjacent to gene bearing strong similarity to the parA/
sopA genes of other bacterial species’ replicons. Each
replicon within an individual B. burgdorferi cell carries a
distinctively diﬀerent pair of parA homolog and bpaB
genes, and those pairings appear to coincide with incom-
patibility groups (18,24,28). These data suggest that, even
though BpaB sequences are dissimilar from characterized
ParB proteins of other bacterial plasmids, BpaB may
perform segregation functions similar to those of typical
ParBs. Bacterial ParB proteins are site-speciﬁc DNA-
binding proteins with aﬃnities for parS DNA sequences
on their replicons, and interactions between ParB, ParA
and parS play roles in replicon segregation. It is possible
that erp Operator 2 regions contain the parS homologue
of cp32 elements, although we feel this to be unlikely due
to ability of all tested cp32 family-encoded BpaB proteins
to bind that DNA. Alternatively, parS may be located
elsewhere on these replicons, while the DNA sequence
within erp Operator 2 directs binding of additional BpaB
molecules for another reason, such as regulation of erp
transcription. Studies are ongoing to determine the con-
sensus high-aﬃnity binding sequence of cp32-encoded
BpaB proteins, and where else these proteins bind on the
replicons.
In conclusion, a new DNA-binding protein of
B. burgdorferi was discovered, and was demonstrated to
bind with high aﬃnity to a DNA sequence within erp
Operator 2. Binding of BpaB at that site led to DNA-
bending and to the binding of additional BpaB molecules.
The high-aﬃnity BpaB-binding site is adjacent to
or overlaps the high-aﬃnity EbfC-binding sites, and
those two proteins were found to compete for binding to
erp Operator 2 DNA. Since that region of DNA is
required for control of erp operon transcription (20), the
present studies suggest that cellular levels of free BpaB
and EbfC may contribute to regulation of erp gene
expression.
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Figure 9. EbfC and BpaB compete for binding to erp Operator 2.
(A) EMSAs in which the concentration of BpaB321 was held
constant while increasing concentrations of EbfC were added.
(Lane 1) Labeled probe b-WT alone. (Lanes 2 and 3) Probe b-WT
preincubated with 2.05 and 2.89mM recombinant EbfC or BpaB321,
respectively. (Lanes 4–12) Probe b-WT preincubated with 0.97mM re-
combinant BpaB321, plus EbfC at concentrations of 0.27, 0.51, 1.03,
1.54, 2.05, 2.56, 3.08, 3.59 and 4.10mM, respectively. Compositions of
EMSA bands are indicated to the right of the panel. Asterisks indicate
nonspeciﬁc DNA binding by EbfC observed at high concentrations of
that protein (our unpublished data). Ratios of free DNA to BpaB–
DNA complex 1 in lanes 4 through 12 were 3.9:1, 3.5:1, 2.7:1,
2.1:1, 1.4:1, 1.1:1, 1.1:1, 0.86:1 and 0.57:1, respectively, with the
BpaB–DNA complex signals remaining constant, indicating that EbfC
preferentially bound to free DNA. Quantiﬁcation of signal intensities
indicated that the proportion of EbfC–DNA complexes steadily
increased with addition of EbfC protein, and that total of signal
strengths remained constant across the EMSA gel. (B) EMSAs in
which the concentration of EbfC was held constant while increasing
concentrations of BpaB321 were added. (Lane 1) Labeled probe b-WT
alone. (Lanes 2 and 3) Probe b-WT pre-incubated with 0.2 and 0.3mM
recombinant EbfC or BpaB321, respectively. (Lanes 4–12) Probe b-WT
preincubated with 0.3mM recombinant BpaB321, plus EbfC at concen-
trations of 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 and 1mM, respectively.
Compositions of EMSA bands are indicated to the right of the panel.
The asterisk indicates nonspeciﬁc DNA binding by EbfC observed at
high concentrations of that protein (our unpublished data).
Quantiﬁcation of signal strengths indicated that proportions of free
DNA and DNA bound by EbfC decreased as additional BpaB was
added, while proportions of BpaB–DNA complexes increased.
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